Caroline Houillier

7.2k total citations
99 papers, 1.9k citations indexed

About

Caroline Houillier is a scholar working on Genetics, Neurology and Pathology and Forensic Medicine. According to data from OpenAlex, Caroline Houillier has authored 99 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Genetics, 73 papers in Neurology and 49 papers in Pathology and Forensic Medicine. Recurrent topics in Caroline Houillier's work include CNS Lymphoma Diagnosis and Treatment (70 papers), Glioma Diagnosis and Treatment (69 papers) and Lymphoma Diagnosis and Treatment (48 papers). Caroline Houillier is often cited by papers focused on CNS Lymphoma Diagnosis and Treatment (70 papers), Glioma Diagnosis and Treatment (69 papers) and Lymphoma Diagnosis and Treatment (48 papers). Caroline Houillier collaborates with scholars based in France, United States and Italy. Caroline Houillier's co-authors include Khê Hoang‐Xuan, Karima Mokhtari, Carole Soussain, Marc Sanson, Sylvain Choquet, Florence Laigle–Donadey, Blandine Boisselier, Gentian Kaloshi, Ahmed Idbaïh and Julien Laffaire and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Neurology.

In The Last Decade

Caroline Houillier

89 papers receiving 1.8k citations

Peers

Caroline Houillier
Kwan Park South Korea
Caroline Houillier
Citations per year, relative to Caroline Houillier Caroline Houillier (= 1×) peers Kwan Park

Countries citing papers authored by Caroline Houillier

Since Specialization
Citations

This map shows the geographic impact of Caroline Houillier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline Houillier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline Houillier more than expected).

Fields of papers citing papers by Caroline Houillier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline Houillier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline Houillier. The network helps show where Caroline Houillier may publish in the future.

Co-authorship network of co-authors of Caroline Houillier

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline Houillier. A scholar is included among the top collaborators of Caroline Houillier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline Houillier. Caroline Houillier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pérol, Louis, Carole Soussain, Khê Hoang‐Xuan, et al.. (2025). ICE polychemotherapy is an efficient salvage treatment in primary central nervous system lymphoma: an LOC network study. Blood Advances. 9(8). 1801–1804. 1 indexed citations
2.
Riche, Maximilien, Karima Mokhtari, Franck Bielle, et al.. (2025). Safety and therapeutic impact of stereotactic biopsy in very elderly patients with brain tumors. Journal of neurosurgery. 143(1). 194–203. 2 indexed citations
3.
Hernández-Verdín, Isaias, Karima Mokhtari, Élise Sourdeau, et al.. (2025). Gut microbiome modulates the outcome in primary central nervous system lymphoma patients undergoing chemotherapy: An ancillary study from the BLOCAGE trial. Neuro-Oncology. 27(8). 2090–2104.
4.
Choquet, Sylvain, Bertrand Mathon, Magali Le Garff‐Tavernier, et al.. (2025). Mild Metabolism Increase on Posttreatment 18F-FDG PET may Indicate Recurrence of Primary CNS Lymphoma. Clinical Nuclear Medicine. 50(11). 1060–1061.
5.
Bielack, Stefan, Carole Soussain, Christopher P. Fox, et al.. (2024). A European consensus recommendation on the management of delayed methotrexate elimination: supportive measures, leucovorin rescue and glucarpidase treatment. Journal of Cancer Research and Clinical Oncology. 150(10). 441–441. 6 indexed citations
6.
Rozenblum, Laura, Caroline Houillier, Amandine Baptiste, et al.. (2024). Interim FDG-PET improves treatment failure prediction in primary central nervous system lymphoma: An LOC network prospective multicentric study. Neuro-Oncology. 26(7). 1292–1301. 2 indexed citations
7.
Houillier, Caroline & Sylvain Choquet. (2024). CAR T-cell Therapy for Central Nervous System Lymphoma. Current Oncology Reports. 26(11). 1521–1529. 2 indexed citations
8.
Armand, Marine, Élise Sourdeau, Karima Mokhtari, et al.. (2023). Combining MYD88 L265P mutation detection and clonality determination on CSF cellular and cell‐free DNA improves diagnosis of primary CNS lymphoma. British Journal of Haematology. 201(6). 1088–1096. 12 indexed citations
9.
Weiss, Nicolas, Sylvain Choquet, Cristina Birzu, et al.. (2023). JS03.6.A NEUROTOXICITY IN PATIENTS WITH CNS LYMPHOMAS TREATED WITH CAR T CELL THERAPY. A LOC NETWORK STUDY. Neuro-Oncology. 25(Supplement_2). ii7–ii8. 1 indexed citations
10.
Dufour, Jean‐François, Sylvain Choquet, Khê Hoang‐Xuan, et al.. (2023). Systemic relapses of primary CNS lymphomas (PCNSL): a LOC network study. Annals of Hematology. 102(5). 1159–1169. 2 indexed citations
11.
Thomas, Alice, Caroline Houillier, D. Antoni, et al.. (2023). Radiotherapy for newly diagnosed primary central nervous system lymphoma: role and perspective. Reports of Practical Oncology & Radiotherapy. 28(2). 271–285.
12.
Roos‐Weil, Damien, Nicolas Weiss, Amélie Guihot, et al.. (2021). Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy: a new gold standard?. Journal of Neurology. 268(7). 2458–2465. 11 indexed citations
13.
Bihan, Kévin, Flavie Bompaire, Caroline Houillier, et al.. (2021). Leukoencephalopathy with transient splenial lesions related to 5‐fluorouracil or capecitabine. European Journal of Neurology. 28(7). 2396–2402. 4 indexed citations
14.
Xochelli, Aliki, Claude Lesty, Nathalie Cassoux, et al.. (2020). Primary vitreoretinal lymphomas display a remarkably restricted immunoglobulin gene repertoire. Blood Advances. 4(7). 1357–1366. 25 indexed citations
15.
Franceschi, Enrico, Didier Frappaz, Roberta Rudà, et al.. (2020). Rare Primary Central Nervous System Tumors in Adults: An Overview. Frontiers in Oncology. 10. 996–996. 12 indexed citations
16.
Costopoulos, Myrto, Rathana Kim, Sylvain Choquet, et al.. (2017). Cerebrospinal fluid interleukin (IL)-10 and IL-10:IL-6 ratio as biomarkers for small B-cell lymphoproliferations with leptomeningeal dissemination. Seminars in Hematology. 55(4). 179–181. 5 indexed citations
17.
Ducray, François, Gentian Kaloshi, Caroline Houillier, et al.. (2013). Ongoing and prolonged response in adult low-grade gliomas treated with radiotherapy. Journal of Neuro-Oncology. 115(2). 261–265. 7 indexed citations
18.
Rio, Monica Sierra del, Damien Ricard, Caroline Houillier, et al.. (2011). Prophylactic intrathecal chemotherapy in primary CNS lymphoma. Journal of Neuro-Oncology. 106(1). 143–146. 42 indexed citations
19.
Houillier, Caroline, Gentian Kaloshi, Karima Mokhtari, et al.. (2010). IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas. Neurology. 75(17). 1560–1566. 402 indexed citations
20.
Roy, Denis‐Claude, et al.. (1996). Elimination of Neuroblastoma and Small-Cell Lung Cancer Cells With an Anti-Neural Cell Adhesion Molecule Immunotoxin. JNCI Journal of the National Cancer Institute. 88(16). 1136–1145. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026